Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report)’s stock price hit a new 52-week low on Friday after StockNews.com downgraded the stock from a hold rating to a sell rating. The stock traded as low as $65.67 and last traded at $66.72, with a volume of 148079 shares traded. The stock had previously closed at $66.73.
Other equities analysts have also issued reports about the company. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a research report on Thursday, April 25th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective for the company in a research report on Friday, January 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, UBS Group upped their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.
Insider Activity at Acadia Healthcare
In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by insiders.
Institutional Trading of Acadia Healthcare
Institutional investors have recently added to or reduced their stakes in the business. Quent Capital LLC lifted its position in shares of Acadia Healthcare by 8.1% in the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after purchasing an additional 284 shares during the period. BNP Paribas Financial Markets raised its position in Acadia Healthcare by 77.1% in the 1st quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock worth $1,700,000 after buying an additional 9,342 shares during the last quarter. Peterson Wealth Services purchased a new stake in Acadia Healthcare in the first quarter worth approximately $2,739,000. Retirement Systems of Alabama lifted its holdings in Acadia Healthcare by 0.3% in the first quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock valued at $9,174,000 after acquiring an additional 303 shares during the period. Finally, OFI Invest Asset Management increased its holdings in Acadia Healthcare by 2.5% during the first quarter. OFI Invest Asset Management now owns 164,427 shares of the company’s stock valued at $12,061,000 after buying an additional 4,013 shares during the last quarter.
Acadia Healthcare Stock Performance
The firm has a market cap of $6.11 billion, a PE ratio of -472.29, a PEG ratio of 2.15 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The business has a 50-day simple moving average of $77.13 and a 200 day simple moving average of $77.61.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. The firm had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.56%. The business’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.75 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.